Building the leading extracellular protein degradation company
11 - 50
💰 $70M Series B on 2021-09
July 19
Lead global regulatory strategy for innovative therapeutics degrading extracellular and membrane-bound proteins.
🇺🇸 United States – Remote
⏰ Full Time
🔴 Lead
🚔 Compliance